Cargando…

Subcellular progression of mesenchymal transition identified by two discrete synchronous cell lines derived from the same glioblastoma

Glioblastomas (GBM) exhibit intratumoral heterogeneity of various oncogenic evolutional processes. We have successfully isolated and established two distinct cancer cell lines with different morphological and biological characteristics that were derived from the same tissue sample of a GBM. When we...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sojin, Park, Soo-Ji, Chowdhury, Tamrin, Hong, Jeong-Im, Ahn, Jinhee, Jeong, Tae Yeong, Yu, Hyeon Jong, Shin, Young-Kyoung, Ku, Ja-Lok, Park, Jong Bae, Hur, Junho K., Lee, Hwajin, Kim, Kyoungmi, Park, Chul‑Kee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918182/
https://www.ncbi.nlm.nih.gov/pubmed/35278143
http://dx.doi.org/10.1007/s00018-022-04188-3
Descripción
Sumario:Glioblastomas (GBM) exhibit intratumoral heterogeneity of various oncogenic evolutional processes. We have successfully isolated and established two distinct cancer cell lines with different morphological and biological characteristics that were derived from the same tissue sample of a GBM. When we compared their genomic and transcriptomic characteristics, each cell line harbored distinct mutation clusters while sharing core driver mutations. Transcriptomic analysis revealed that one cell line was undergoing a mesenchymal transition process, unlike the other cell line. Furthermore, we could identify four tumor samples containing our cell line-like clusters from the publicly available single-cell RNA-seq data, and in a set of paired longitudinal GBM samples, we could confirm three pairs where the recurrent sample was enriched in the genes specific to our cell line undergoing mesenchymal transition. The present study provides direct evidence and a valuable source for investigating the ongoing process of subcellular mesenchymal transition in GBM, which has prognostic and therapeutic implications. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-022-04188-3.